| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5B | $1.4B | $6.9B | $7.4B | $5.7B | $5.4B | $5.5B | $5.5B |
| Cost of Revenue | $5.9B | $4.2B | $5.3B | $5.8B | $4.5B | $4.2B | $4.3B | $4.3B |
| Gross Profit | $1.6B | $0.3B | $1.4B | $1.4B | $1.1B | $1.0B | $0.2B | $0.3B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.9B | $0.7B | $0.7B | $0.7B | $0.6B | $0.5B | $0.5B | $0.6B |
| Operating Income | $1.0B | $0.3B | $0.7B | $0.7B | $0.5B | $0.4B | $0.5B | $0.4B |
| Net Income | $1.0B | $-0.0B | $0.5B | $0.5B | $-0.1B | $0.2B | $0.0B | $0.1B |
| EPS (Basic) | $10.12 | $-0.44 | $4.83 | $4.76 | $-0.86 | $2.06 | $0.45 | $0.78 |
| EPS (Diluted) | $10.07 | $-0.44 | $4.80 | $4.72 | $-0.86 | $2.05 | $0.44 | $0.77 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.2B | $12.5B | $7.2B | $7.1B | $5.1B | $5.3B | $5.1B | $4.6B |
| Current Assets | $2.6B | $3.2B | $2.1B | $2.4B | $1.7B | $1.8B | $1.5B | $1.5B |
| Cash & Equivalents | $0.4B | $0.4B | $0.2B | $0.2B | $0.2B | $0.6B | $0.1B | $0.1B |
| Total Liabilities | $7.5B | $10.2B | — | — | — | — | — | — |
| Current Liabilities | $2.5B | $4.0B | $1.2B | $1.7B | $1.5B | $1.5B | $1.4B | $1.1B |
| Stockholders' Equity | $3.6B | $2.3B | $2.4B | $2.1B | $1.8B | $1.9B | $1.8B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.8B | $0.9B | $0.5B | $0.3B | $0.7B | $0.4B | $0.6B |
| Investing Cash Flow | $2.2B | $-4.1B | $-0.6B | $-1.7B | $-0.2B | $-0.1B | $-0.5B | $-0.4B |
| Capital Expenditures | $0.3B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-3.0B | $3.7B | $-0.4B | $1.3B | $-0.5B | $-0.2B | $0.1B | $-0.3B |